Glucagon and its Family Revisited
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Considered for decades as a contaminant of insulin preparations, gluca-gon was among the very first hormones to be isolated, purified, sequenced, and synthesized during the late 1950s. The field of glucagon research exploded after R.H. Unger and his colleagues in Dallas, TX, described a method permitting its measurement in the plasma by radioimmunoassay. Such assay made it possible to firmly establish the basic principles of glucagon physiology and to discover its pathophysiology. More recently, important progress has been made in exploring the molecular biology of this hormone: the glucagon gene and the glu-cagon-receptor gene have been identified and their expression investigated. Furthermore, the processing of the glucagon gene product has been elucidated and the function of the members of the glucagon family has been clarified. Finally, current investigations are in progress to develop glucagon agonists and antagonists and to identify new modes of administration of the hormone. These various topics will be considered in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Drucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., & Habener, J. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3434 · Cited by 903 · cited 1×
“As reviewed by Thorens and Waeber (149), GLP-I exerts clear-cut effects on the pancreatic /3-cell: a glucose-dependent stimulation of insulin secretion (150-152), a stimulation of insulin gene transcription, and an accumulation of insulin in secretory granules (153,154), this latter effect most likely being mediated b…”
BackgroundGutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868 · cited 1×
“Indeed, intravenous infusion of GLP-I normalizes fasting hyperglycemia in NIDDM patients (162).”
BackgroundGerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science · doi:10.1126/science.182.4108.171 · Cited by 688
Mitrakou, A., Ryan, C., Veneman, T., Mokan, M., Jenssen, T., Kiss, I., Durrant, J., Cryer, P., & Gerich, J. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.1.e67 · Cited by 558 · cited 1×
“Numerous studies, reviewed by Gerich (70), have shown that in order of importance, the key counterregulatory factors (111) are glucagon, epinephrine, growth hormone, cortisol, and hepatic autoregulation.”
BackgroundFanelli, C. G., Epifano, L., Rambotti, A. M., Pampanelli, S., Di Vincenzo, A., Modarelli, F., Lepore, M., Annibale, B., Ciofetta, M., Bottini, P., et al. (1993) · Diabetes · doi:10.2337/diab.42.11.1683 · Cited by 398
White, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391 · cited 1×
“Loss of adequate counterregulation is associated with a major increase in the incidence of severe hypoglycemic episodes (118).”
BackgroundInsulin within islets is a physiologic glucagon release inhibitor
Maruyama, H., Hisatomi, A., Orci, L., Grodsky, G. M., & Unger, R. H. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111658 · Cited by 303
Brief, Irregular Oscillations of Basal Plasma Insulin and Glucose Concentrations in Diabetic Man
Lang, D. A., Matthews, D. R., Burnett, M., & Turner, R. C. (1981) · Diabetes · doi:10.2337/diab.30.5.435 · Cited by 279
Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus
Epstein, F. H., Cryer, P. E., & Gerich, J. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507253130405 · Cited by 273
Cited by
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Gelling, R. W., Du, X. Q., Dichmann, D. S., Rømer, J., Huang, H., Cui, L., Obici, S., Tang, B., Holst, J. J., Fledelius, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237106100 · Cited by 563
Glucose Metabolism and Regulation: Beyond Insulin and Glucagon
Aronoff, S. L., Berkowitz, K., Shreiner, B., & Want, L. (2004) · Diabetes Spectrum · doi:10.2337/diaspect.17.3.183 · Cited by 569
Insulin Resistance with Aging: Effects of Diet and Exercise
Ryan, A. S. (2000) · Sports Medicine · doi:10.2165/00007256-200030050-00002 · Cited by 282
Meier, J. J., Nauck, M. A., Pott, A., Heinze, K., Goetze, O., Bulut, K., Schmidt, W. E., Gallwitz, B., & Holst, J. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.004 · Cited by 266
Metadata
- Authors
- Lefèbvre, P. J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1995-05-01
- Volume
- 18
- Issue
- 5
- Pages
- 715-730
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2072271284
- Cited by
- 113
- References
- 14
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucagon and its Family Revisited. https://app.cochat.ai/papers/10.2337/diacare.18.5.715
- The paper
- Lefèbvre, P. J. (1995). Glucagon and its Family Revisited. Diabetes Care. https://doi.org/10.2337/diacare.18.5.715
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.